http://www.sfgate.com/bayarea/article/Cancer-breakthrough-97-percent-of-mice-cured-in-12547552.php
Excerpt:
A Stanford University study targeting cancer cells in laboratory mice has been generating buzz and hope.
A new experiment for cancer treatment had incredible results using immune-stimulators to target tumors in mice. Specifically activating T cells in tumors eliminated even distant metastases in mice, according to a study published this week by researchers at the Stanford University School of Medicine.
The approach worked surprisingly well in laboratory mice with transplanted mouse lymphoma tumors in two sites on their bodies. Injecting one tumor site with the two agents caused the regression of both the treated tumor as well as the second untreated tumor.
In all, 87 of 90 mice were cured of the cancer. Although the cancer recurred in three of the mice, the tumors again regressed after a second treatment, according to the peer-reviewed research.
Excerpt:
A Stanford University study targeting cancer cells in laboratory mice has been generating buzz and hope.
A new experiment for cancer treatment had incredible results using immune-stimulators to target tumors in mice. Specifically activating T cells in tumors eliminated even distant metastases in mice, according to a study published this week by researchers at the Stanford University School of Medicine.
The approach worked surprisingly well in laboratory mice with transplanted mouse lymphoma tumors in two sites on their bodies. Injecting one tumor site with the two agents caused the regression of both the treated tumor as well as the second untreated tumor.
In all, 87 of 90 mice were cured of the cancer. Although the cancer recurred in three of the mice, the tumors again regressed after a second treatment, according to the peer-reviewed research.